Company news
Beijing Konruns Pharmaceutical Co., Ltd. Class A (SSE:603590) news
Beijing Konruns Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Aug 28, 2025: Announcement on Resolutions of the 15th Meeting of the 4th Board…
Press releases — page 2
Announcement on Resolutions of the 15th Meeting of the 4th Board of Supervisors
August 27, 2025
Announcement on Completion of the First Subject Enrollment in the Phase 1 Clinical Trial of KC1086
August 21, 2025
Announcement on Resolutions of the 18th Meeting of the 4th Board of Directors
August 11, 2025
Announcement on Foreign Investment by Wholly-owned Subsidiary
July 22, 2025
Announcement on Risk Warning of Stock Trading
July 14, 2025
Announcement on Obtaining Notice of Clinical Trial for Project KC1086
July 2, 2025
Announcement on Resolution of the 14th Meeting of the 4th Board of Supervisors
June 23, 2025